Deep, focused upcoming-era sequencing has disclosed that subclonal mutations (i.e., those existing in only a portion of tumor cells) can be detected for all driver genes and therefore are associated with swift illness progression and weak end result.11–thirteen This is particularly pertinent for TP53 mutations presented The point that, as https://emilel370los1.blue-blogs.com/profile